Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from BiomX ( (PHGE) ).
On April 10, 2026, BiomX Inc. closed the acquisition of Israeli AI defense technology firm ZorroNet from Water IO, issuing 1.3 million shares and a $1.25 million non-convertible note due July 7, 2026 as consideration. The deal also includes a performance-based earnout tied to ZorroNet’s 2026 revenue or EBITDA and commitments to retain key personnel for three years on comparable terms.
ZorroNet develops AI-powered command-and-control and autonomous surveillance software that fuses video analytics, drones, sensors and IoT devices into a unified operational intelligence layer for real-time threat detection and response. Its systems are already deployed with the Israel Defense Forces, Israel Railways, Elbit Systems and other defense and critical infrastructure customers, providing BiomX with production-grade, revenue-generating capabilities.
BiomX said the acquisition is immediately accretive and marks its formal entry into the defense, security and rescue sectors, positioning the company as an AI-powered defense technology platform with an established customer base. The move complements its option to acquire Israeli LADAR specialist DFSL and targets fast-growing global command-and-control and video analytics markets, where rising demand for integrated situational awareness and AI-enabled decision support is reshaping security operations.
The most recent analyst rating on (PHGE) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.
Spark’s Take on PHGE Stock
According to Spark, TipRanks’ AI Analyst, PHGE is a Neutral.
PHGE scores low primarily due to weak financial performance (no revenue, persistent cash burn, and negative equity) and bearish technicals (price below key moving averages with negative MACD and weak RSI). Valuation offers limited support given a negative P/E and no dividend, while the earnings call and corporate events are mixed but dominated by liquidity, clinical/regulatory, and listing/going-concern risks.
To see Spark’s full report on PHGE stock, click here.
More about BiomX
BiomX Inc., listed on the NYSE American, is repositioning itself as an AI-first defense technology platform. Through recent deals it is building a diversified portfolio in defense, rescue and security, targeting global demand for autonomous intelligence, surveillance and reconnaissance, AI-enabled threat detection, smart border security and counter-drone solutions.
The company’s new focus centers on integrating AI-powered command-and-control, video analytics and advanced sensing technologies into mission-critical environments. With contracts and collaborations spanning military, government and critical infrastructure customers, BiomX aims to capture growth in the expanding command-and-control and video analytics markets projected to reach tens of billions of dollars by 2030.
Average Trading Volume: 1,025,545
Technical Sentiment Signal: Sell
Current Market Cap: $19.57M
See more insights into PHGE stock on TipRanks’ Stock Analysis page.

